Standard BioTools

LAB63

Penny Stock

$2.08arrow_drop_up1.21%$0.02

Penny Stock

LAB63

$2.08

arrow_drop_up1.21%$0.02

Penny Stock

Performance History

Key Stats
Open	$2.06
Prev. Close	$2.06
EPS	-0.88
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$764.57M
PE Ratio	-

	LOW	HIGH
Day Range	2.00	2.08
52 Week Range	1.21	3.05

Ratios







EPS	-0.88

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Standard BioTools (LAB)

Standard BioTools Inc. (LAB) is a leading provider of innovative laboratory instruments and solutions in the biotechnology industry. With a rich history dating back over three decades, Standard BioTools has established itself as a trusted name in the field of biosciences. The company's stock price history reflects its consistent growth and strong performance. Over the years, LAB stock has shown steady upward trends, reflecting the market's confidence in the company's products and services.

Standard BioTools is dedicated to revolutionizing the way research is conducted in the life sciences sector. The company offers a wide range of cutting-edge instruments, including next-generation sequencing platforms, PCR systems, and advanced imaging tools. These state-of-the-art technologies enable scientists and researchers to accelerate their discoveries and advance their understanding of the biological world.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Dr. Michael Egholm Ph.D.
Headquarters: South San Francisco
Employees: 523
Exchange: NASDAQ

Keep an eye on Standard BioTools

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Standard BioTools's (LAB) price per share?

The current price per share for Standard BioTools (LAB) is $2.08. The stock has seen a price change of $0.02 recently, indicating a 1.21% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Standard BioTools (LAB)?

For Standard BioTools (LAB), the 52-week high is $3.05, which is 46.28% from the current price. The 52-week low is $1.21, the current price is 72.31% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Standard BioTools (LAB) a growth stock?

Standard BioTools (LAB) has shown an average price growth of 0.41% over the past three years. It has received a score of 34 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Standard BioTools as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Standard BioTools (LAB) stock price performance year to date (YTD)?

As of the latest data, Standard BioTools (LAB) has a year-to-date price change of -6.08%. Over the past month, the stock has experienced a price change of 15.83%. Over the last three months, the change has been -1.18%. Over the past six months, the figure is -20.42%.

help

Is Standard BioTools (LAB) a profitable company?

Standard BioTools (LAB) has a net income of -$74.66M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 47.44% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -29.42% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $106.34M, with a revenue growth rate of 8.57%, providing insight into the company's sales performance and growth. The gross profit is $50.45M. Operating income is noted at -$63.04M. Furthermore, the EBITDA is -$104.31M.

help

What is the market capitalization of Standard BioTools (LAB)?

Standard BioTools (LAB) has a market capitalization of $764.58M. The average daily trading volume is 1.44M, indicating the stock's liquidity and investor engagement.